長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【2183】リニカル

【2183】リニカル
CRO。
類似企業：


東証プライム
サー
＞
治験
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/14 Q2予 11,468 ↓ -9.5% -9.5% 250 ↓ -75.2% -75.2% 258 ↓ -75.4% -75.4% 150 ↓ -78.5% -78.5%
2025.03 2024/08/14 Q1予 12,669 → 0.0% 0.0% 1,009 → 0.0% 0.0% 1,047 → 0.0% 0.0% 697 → 0.0% 0.0%
2025.03 2024/05/15 当初予 12,669 - - - 1,009 - - - 1,047 - - - 697 - - -
2024.03 2024/05/15 実 12,307 ↑ +0.2% -7.5% 725 ↑ +1.1% -48.2% 790 ↓ -0.5% -43.6% 338 ↑ +10.1% -66.5%
2024.03 2024/04/12 修正予 12,280 ↑ +3.2% -7.7% 717 ↑ +110.9% -48.8% 794 ↑ +140.6% -43.3% 307 ↑ - -69.5%
2024.03 2024/02/14 Q3予 11,900 ↓ -10.5% -10.5% 340 ↓ -75.7% -75.7% 330 ↓ -76.4% -76.4% 0 ↓ -100.0% -100.0%
2024.03 2023/11/14 Q2予 13,300 → 0.0% 0.0% 1,400 → 0.0% 0.0% 1,400 → 0.0% 0.0% 1,008 → 0.0% 0.0%
2024.03 2023/08/14 Q1予 13,300 → 0.0% 0.0% 1,400 → 0.0% 0.0% 1,400 → 0.0% 0.0% 1,008 → 0.0% 0.0%
2024.03 2023/05/15 当初予 13,300 - - - 1,400 - - - 1,400 - - - 1,008 - - -
2023.03 2023/05/15 実 12,516 ↑ +0.6% +0.6% 1,256 ↑ +2.6% +2.6% 1,283 ↑ +6.6% +6.6% 1,004 ↑ +15.3% +15.3%
2023.03 2023/02/14 Q3予 12,440 → 0.0% 0.0% 1,224 → 0.0% 0.0% 1,204 → 0.0% 0.0% 871 → 0.0% 0.0%
2023.03 2022/11/14 Q2予 12,440 → 0.0% 0.0% 1,224 → 0.0% 0.0% 1,204 → 0.0% 0.0% 871 → 0.0% 0.0%
2023.03 2022/08/12 Q1予 12,440 → 0.0% 0.0% 1,224 → 0.0% 0.0% 1,204 → 0.0% 0.0% 871 → 0.0% 0.0%
2023.03 2022/05/16 当初予 12,440 - - - 1,224 - - - 1,204 - - - 871 - - -
2022.03 2022/05/16 実 11,555 → 0.0% +8.0% 1,085 → 0.0% +58.9% 1,183 → 0.0% +73.2% 790 → 0.0% 0.0%
2022.03 2022/05/13 修正予 11,555 ↑ +0.5% +8.0% 1,085 ↑ +19.8% +58.9% 1,183 ↑ +25.7% +73.2% 790 - - -
2022.03 2022/03/28 修正予 11,500 ↑ +7.5% +7.5% 906 ↑ +32.7% +32.7% 941 ↑ +37.8% +37.8% - - - -
2022.03 2022/02/14 Q3予 10,700 → 0.0% 0.0% 683 → 0.0% 0.0% 683 → 0.0% 0.0% - - - -
2022.03 2021/11/12 Q2予 10,700 → 0.0% 0.0% 683 → 0.0% 0.0% 683 → 0.0% 0.0% - - - -
2022.03 2021/08/12 Q1予 10,700 → 0.0% 0.0% 683 → 0.0% 0.0% 683 → 0.0% 0.0% - - - -
2022.03 2021/05/14 当初予 10,700 - - - 683 - - - 683 - - - - - - -
2021.03 2021/05/14 実 10,279 - - - 453 - - - 588 - - - 539 - - -
2020.03 2020/05/25 実 10,935 ↓ -6.5% -6.5% 1,005 ↓ -35.6% -35.6% 918 ↓ -40.3% -40.3% 482 ↓ -50.4% -50.4%
2020.03 2020/02/14 Q3予 11,700 → 0.0% 0.0% 1,560 → 0.0% 0.0% 1,538 → 0.0% 0.0% 971 → 0.0% 0.0%
2020.03 2019/11/14 Q2予 11,700 → 0.0% 0.0% 1,560 → 0.0% 0.0% 1,538 → 0.0% 0.0% 971 → 0.0% 0.0%
2020.03 2019/08/14 Q1予 11,700 → 0.0% 0.0% 1,560 → 0.0% 0.0% 1,538 → 0.0% 0.0% 971 → 0.0% 0.0%
2020.03 2019/05/15 当初予 11,700 - - - 1,560 - - - 1,538 - - - 971 - - -
2019.03 2019/05/15 実 11,313 ↓ -0.3% -13.6% 1,212 ↓ -4.4% -40.3% 1,253 ↑ +0.8% -37.1% 568 ↑ +5.4% -57.3%
2019.03 2019/02/14 Q3予 11,350 ↓ -4.6% -13.4% 1,268 ↓ -22.9% -37.6% 1,243 ↓ -27.8% -37.6% 539 ↓ -47.3% -59.4%
2019.03 2018/11/14 Q2予 11,894 ↓ -9.2% -9.2% 1,645 ↓ -19.0% -19.0% 1,722 ↓ -13.6% -13.6% 1,023 ↓ -23.0% -23.0%
2019.03 2018/08/14 Q1予 13,100 → 0.0% 0.0% 2,031 → 0.0% 0.0% 1,993 → 0.0% 0.0% 1,329 → 0.0% 0.0%
2019.03 2018/05/15 当初予 13,100 - - - 2,031 - - - 1,993 - - - 1,329 - - -
2018.03 2018/05/15 実 9,113 ↑ +1.3% -4.4% 1,846 ↑ +7.0% -21.9% 1,826 ↑ +6.6% -22.0% 1,295 ↑ +10.5% -19.2%
2018.03 2018/02/13 Q3予 9,000 ↓ -5.5% -5.5% 1,725 ↓ -27.1% -27.1% 1,713 ↓ -26.9% -26.9% 1,172 ↓ -26.8% -26.8%
2018.03 2017/11/13 Q2予 9,528 → 0.0% 0.0% 2,365 → 0.0% 0.0% 2,342 → 0.0% 0.0% 1,602 → 0.0% 0.0%
2018.03 2017/08/14 Q1予 9,528 → 0.0% 0.0% 2,365 → 0.0% 0.0% 2,342 → 0.0% 0.0% 1,602 → 0.0% 0.0%
2018.03 2017/05/15 当初予 9,528 - - - 2,365 - - - 2,342 - - - 1,602 - - -
2017.03 2017/05/15 実 8,355 ↓ -3.2% -3.2% 2,128 ↑ +2.6% +2.6% 2,076 ↑ +0.8% +0.8% 1,447 ↑ +5.1% +5.1%
2017.03 2017/02/10 Q3予 8,633 → 0.0% 0.0% 2,075 → 0.0% 0.0% 2,060 → 0.0% 0.0% 1,377 → 0.0% 0.0%
2017.03 2016/11/11 Q2予 8,633 → 0.0% 0.0% 2,075 → 0.0% 0.0% 2,060 → 0.0% 0.0% 1,377 → 0.0% 0.0%
2017.03 2016/08/10 Q1予 8,633 → 0.0% 0.0% 2,075 → 0.0% 0.0% 2,060 → 0.0% 0.0% 1,377 → 0.0% 0.0%
2017.03 2016/05/13 当初予 8,633 - - - 2,075 - - - 2,060 - - - 1,377 - - -
2016.03 2016/05/13 実 7,666 → 0.0% +16.4% 2,012 → 0.0% +62.9% 1,985 → 0.0% +62.0% 1,330 → 0.0% +77.6%
2016.03 2016/05/12 修正予 7,666 ↑ +2.1% +16.4% 2,012 ↑ +16.7% +62.9% 1,985 ↑ +18.4% +62.0% 1,330 ↑ +23.4% +77.6%
2016.03 2016/02/10 Q3予 7,510 → 0.0% +14.0% 1,724 → 0.0% +39.6% 1,677 → 0.0% +36.9% 1,078 → 0.0% +43.9%
2016.03 2016/01/29 修正予 7,510 ↑ +14.0% +14.0% 1,724 ↑ +39.6% +39.6% 1,677 ↑ +36.9% +36.9% 1,078 ↑ +43.9% +43.9%
2016.03 2015/11/12 Q2予 6,586 → 0.0% 0.0% 1,235 → 0.0% 0.0% 1,225 → 0.0% 0.0% 749 → 0.0% 0.0%
2016.03 2015/08/13 Q1予 6,586 → 0.0% 0.0% 1,235 → 0.0% 0.0% 1,225 → 0.0% 0.0% 749 → 0.0% 0.0%
2016.03 2015/05/15 当初予 6,586 - - - 1,235 - - - 1,225 - - - 749 - - -
2015.03 2015/05/15 実 4,872 ↑ +0.5% +0.5% 876 ↓ -14.4% -14.4% 840 ↓ -17.6% -17.6% 437 ↓ -29.4% -29.4%
2015.03 2015/02/12 Q3予 4,846 → 0.0% 0.0% 1,023 → 0.0% 0.0% 1,020 → 0.0% 0.0% 619 → 0.0% 0.0%
2015.03 2014/10/31 Q2予 4,846 → 0.0% 0.0% 1,023 → 0.0% 0.0% 1,020 → 0.0% 0.0% 619 → 0.0% 0.0%
2015.03 2014/07/31 Q1予 4,846 → 0.0% 0.0% 1,023 → 0.0% 0.0% 1,020 → 0.0% 0.0% 619 → 0.0% 0.0%
2015.03 2014/05/12 当初予 4,846 - - - 1,023 - - - 1,020 - - - 619 - - -
2014.03 2014/05/12 実 3,721 ↑ +0.5% +0.5% 706 ↑ +1.4% +1.4% 703 ↑ +1.4% +1.4% 449 ↑ +7.9% +7.9%
2014.03 2014/02/24 当初予 3,703 - - - 696 - - - 693 - - - 416 - - -
シェア ツイート
ページトップへ戻る